Global Patent Index - EP 2534479 A1

EP 2534479 A1 20121219 - METHODS OF NORMALIZING MEASURED DRUG CONCENTRATIONS AND TESTING FOR NON-COMPLIANCE WITH A DRUG TREATMENT REGIMEN

Title (en)

METHODS OF NORMALIZING MEASURED DRUG CONCENTRATIONS AND TESTING FOR NON-COMPLIANCE WITH A DRUG TREATMENT REGIMEN

Title (de)

VERFAHREN ZUR NORMALISIERUNG VON GEMESSENEN WIRKSTOFFKONZENTRATIONEN UND ZUR ÜBERPRÜFUNG AUF NON-COMPLIANCE BEI EINEM ARZNEIMITTELBEHANDLUNGSPLAN

Title (fr)

PROCÉDÉS DE NORMALISATION DE CONCENTRATIONS DE MÉDICAMENTS MESURÉES ET TEST POUR DÉTECTER LA NON OBSERVANCE D'UN RÉGIME DE TRAITEMENT MÉDICAMENTEUX

Publication

EP 2534479 A1 20121219 (EN)

Application

EP 10706831 A 20100218

Priority

  • US 70416910 A 20100211
  • US 70418610 A 20100211
  • US 2010024581 W 20100218

Abstract (en)

[origin: WO2011099984A1] Methods for monitoring subject compliance with a prescribed treatment regimen are disclosed. In one embodiment, the method comprises measuring a drug level in fluid of a subject and normalizing said measured drug level as a function of one or more parameters associated with the subject. The normalized drug level is compared to a reference value and associated confidence intervals or to a concentration range. The reference value and associated confidence intervals and/or the concentration range may be normalized based on one or more parameters associated with subjects in a reference population.

IPC 8 full level

G01N 33/50 (2006.01)

CPC (source: EP)

G01N 33/9486 (2013.01); G01N 2800/52 (2013.01)

Citation (search report)

See references of WO 2011099984A1

Citation (examination)

  • DATABASE MEDLINE [online] US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US; June 2004 (2004-06-01), BÉZIE YVONNICK ET AL: "Compliance with methadone-based substitutive treatment: a proposed model based on immunoassay urinary sample screening.", Database accession no. NLM15167627 & BÉZIE YVONNICK ET AL: "Compliance with methadone-based substitutive treatment: a proposed model based on immunoassay urinary sample screening.", THERAPEUTIC DRUG MONITORING, vol. 26, no. 3, June 2004 (2004-06-01), pages 271 - 276, XP009180537, ISSN: 0163-4356
  • M. E.M. LARSON ET AL: "Quantification of a Methadone Metabolite (EDDP) in Urine: Assessment of Compliance", CLINICAL MEDICINE & RESEARCH, vol. 7, no. 4, 1 December 2009 (2009-12-01), pages 134 - 141, XP055065087, ISSN: 1539-4182, DOI: 10.3121/cmr.2009.859
  • EDWARD J. CONE ET AL: "Normalization of Urinary Drug Concentrations with Specific Gravity and Creatinine", JOURNAL OF ANALYTICAL TOXICOLOGY., vol. 33, 1 January 2009 (2009-01-01), US, pages 1 - 7, XP055143799, ISSN: 0146-4760

Designated contracting state (EPC)

AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

DOCDB simple family (publication)

WO 2011099984 A1 20110818; AU 2010345740 A1 20120920; AU 2010345740 A2 20120913; AU 2010345741 A1 20120920; AU 2010345741 A2 20120913; CA 2789241 A1 20110818; CA 2789377 A1 20110818; EP 2534478 A1 20121219; EP 2534479 A1 20121219; JP 2013519876 A 20130530; JP 2013519877 A 20130530; JP 5796873 B2 20151021; WO 2011099985 A1 20110818

DOCDB simple family (application)

US 2010024581 W 20100218; AU 2010345740 A 20100218; AU 2010345741 A 20100218; CA 2789241 A 20100218; CA 2789377 A 20100218; EP 10705713 A 20100218; EP 10706831 A 20100218; JP 2012552850 A 20100218; JP 2012552851 A 20100218; US 2010024587 W 20100218